mcspc: treatment after progression on ar-targeted therapy
Published 4 years ago • 58 plays • Length 5:10Download video MP4
Download video MP3
Similar videos
-
4:50
card trial: cabazitaxel after ar-targeted therapy in mcspc
-
7:52
case 3: treatment after progression to mcrpc
-
1:46
os after progression on first novel hormonal therapy in mcspc vs mcrpc
-
3:13
treatment options in metastatic prostate cancer
-
7:07
ep. 13: avoiding repeat lines of ar-targeted therapy in mcrpc
-
6:37
case 2: sequencing therapy in mcspc
-
3:51
impressions of a patient with progression to mcrpc
-
0:36
treating patients with progressive metastatic castration-resistant prostate cancer
-
9:00
differences between ar-targeted therapy in prostate cancer
-
8:30
ar-targeted therapies in crpc
-
3:24
progression of metastatic prostate cancer defined
-
2:24
survival outcomes and characterization of mcspc
-
3:06
how ar therapy has changed the nmcrpc treatment landscape
-
3:09
mcrpc: sequencing therapy
-
39:02
systemic therapies for the treatment of advanced prostate cancer
-
4:55
bone targeted therapy for metastatic prostate cancer
-
1:56
dr. oh on targeted treatment in metastatic castration-resistant prostate cancer
-
6:57
case 1: patient choice in initiating ar-targeted therapy in nmcrpc
-
0:45
treatment sequencing for metastatic castration-resistant prostate cancer